Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19

NCT04543006 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT04543006
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04543006 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19
Lead sponsor
University Hospital, Grenoble
Phase
Not applicable
Overall status
Unknown status
Start date
September 8, 2020
Completion date
December 31, 2021
Enrollment
170 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

covid19